Browsing by Author Montes Moreno, Santiago
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) |
|---|---|---|
| 26-Apr-2022 | CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma | Roncador, Giovanna; Puñet Ortiz, Joan; Maestre, Lorena; Rodríguez-Lobato, Luis Gerardo; Jiménez, Scherezade; Reyes García, Ana Isabel; García-González, Álvaro; García, Juan F.; Piris, Miguel A.; Montes Moreno, Santiago; Rodríguez-Justo, Manuel; Mena, Mari-Pau; Fernández de Larrea Rodríguez, Carlos José; Engel Rocamora, Pablo |
| 8-Sep-2014 | NF-κB directly mediates epigenetic deregulation of common microRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomas | Vento Tormo, Roser; Rodríguez Ubreva, Javier; Lisio, Lorena Di; Islam, Abul B. M. M. K.; Urquiza, José M.; Hernando, Henar; López Bigas, Núria; Shannon-Lowe, Claire; Martínez, Nerea; Montes Moreno, Santiago; Piris, Miguel A.; Ballestar Tarín, Esteban |
| 1-Aug-2014 | Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis | Montes Moreno, Santiago; Batlle, Ana; González de Villambrosía, Sonia; Sánchez-Espiridión, Beatriz; Cereceda, Laura; González Barca, Eva; Purroy, Noelia; Pardal, Emilia; Martín, Alejandro; Grande, Carlos; Mazorra, Francisco; Insunza, Andrés; Quero, Cristina; Aguiar, David; Cruz, Miguel Ángel; Rueda Dominguez, Antonio; Llanos, Marta; Gómez Codina, Jose; García Arroyo, Francisco Ramón; Caballero, Dolores; Conde, Eulogio; López, Andres; Provencio, Mariano; Piris, Miguel A. |
| 17-Aug-2018 | Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma | González Barca, Eva; Coronado, Mónica; Martin, Alejandro; Montalbán, Carlos; Montes Moreno, Santiago; Panizo, Carlos Manuel; Rodríguez, Guillermo; Sancho, Juan Manuel; López-Hernández, Andrés; Spanish Lymphoma Group (GELTAMO) |
| 5-Apr-2016 | Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker | Batlle López, Ana; González de Villambrosía, Sonia; Francisco, Mazorra; Malatxeberria, Sefora; Sáez, Anabel; Montalbán, Carlos; Sánchez, Lydia; García, Joan; González Barca, Eva; López-Hernández, Andrés; Ruiz-Marcellan, M. Carmen; Mollejo, Manuela; Grande, Cristina; Richards, Kristy L.; Hsi Eric D.; Tzankov, Alexandar; Visco, Carlo; Xu-Monette, Zijun Y.; Cao, Xin; Young, Ken H.; Piris, Miguel A.; Conde, Eulogio; Montes Moreno, Santiago |